- Home
- ATXG vs TTNP Comparison
ATXG vs TTNP Comparison
Compare ATXG & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- TTNP
- Stock Information
- Founded
- ATXG 2014
- TTNP 1991
- Country
- ATXG China
- TTNP United States
- Employees
- ATXG N/A
- TTNP N/A
- Industry
- ATXG Professional Services
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATXG Consumer Discretionary
- TTNP Health Care
- Exchange
- ATXG Nasdaq
- TTNP Nasdaq
- Market Cap
- ATXG 4.0M
- TTNP 3.4M
- IPO Year
- ATXG N/A
- TTNP 1996
- Fundamental
- Price
- ATXG $0.75
- TTNP $4.65
- Analyst Decision
- ATXG
- TTNP
- Analyst Count
- ATXG 0
- TTNP 0
- Target Price
- ATXG N/A
- TTNP N/A
- AVG Volume (30 Days)
- ATXG 3.0M
- TTNP 80.9K
- Earning Date
- ATXG 07-14-2025
- TTNP 05-14-2025
- Dividend Yield
- ATXG N/A
- TTNP N/A
- EPS Growth
- ATXG N/A
- TTNP N/A
- EPS
- ATXG N/A
- TTNP N/A
- Revenue
- ATXG $4,549,310.00
- TTNP N/A
- Revenue This Year
- ATXG N/A
- TTNP N/A
- Revenue Next Year
- ATXG N/A
- TTNP N/A
- P/E Ratio
- ATXG N/A
- TTNP N/A
- Revenue Growth
- ATXG N/A
- TTNP N/A
- 52 Week Low
- ATXG $0.49
- TTNP $3.03
- 52 Week High
- ATXG $1.86
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- ATXG 50.77
- TTNP 53.37
- Support Level
- ATXG $0.70
- TTNP $4.16
- Resistance Level
- ATXG $1.06
- TTNP $5.12
- Average True Range (ATR)
- ATXG 0.15
- TTNP 0.44
- MACD
- ATXG 0.01
- TTNP -0.01
- Stochastic Oscillator
- ATXG 39.22
- TTNP 51.54
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.